期刊文献+

格列美脲与门冬胰岛素30联合治疗2型糖尿病患者疗效观察 被引量:1

暂未订购
导出
摘要 本研究观察36例使用门冬胰岛素30联合格列美脲治疗2型糖尿病患者的疗效。现总结报告如下。资料与方法一般资料:2011年6月~2012年9月收治正使用每口2次门冬胰岛素30注射液治疗但皿糖不达标的2型糖尿病患者36例,男20例,女16例,诊断符合1999年WHO糖尿病诊断标准[1]。
出处 《中国社区医师(医学专业)》 2013年第7期39-39,共1页
  • 相关文献

参考文献3

二级参考文献21

  • 1喻明,周健,项坤三,陆惠娟,马晓静,陆蔚.动态监测糖耐量正常者血糖水平的漂移变化[J].中华医学杂志,2004,84(21):1788-1790. 被引量:50
  • 2周健,喻明,贾伟平,李青,李鸣,马晓静,陆蔚,项坤三.应用动态血糖监测系统评估2型糖尿病患者日内及日间血糖波动幅度[J].中华内分泌代谢杂志,2006,22(3):286-288. 被引量:178
  • 3American Diabetes Association: The pharmacological treatment of hyperglycemia in NIDD-M. Diabetes Care, 1995, 18(11): 1510-1518.
  • 4American Diabetes Association: Guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance (Position Statement). Diabetes Care, 1997, 20(Suppl. 1 ): S21.
  • 5Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of Randomized clinical trials: is blinding necessary? Control Clin Trials, 1996, 17(1): 1-12.
  • 6Roberts VL, Stewart J, Issa M, et al. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther, 2005, 27(10): 1535-1547.
  • 7Madsbad S, Schmitz O, Ranstam l, et al. Improved glycemic control with no weight increase in patients with type 2 diabetes after oncedaily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211). Diabetes Care, 2004, 27(6): 1335-1342.
  • 8Luis Bautista J, Bugos C, Dirnberger G, et al. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study, clinical therapeutics, 2003, 25(1): 194-209.
  • 9DS Schade, L Jovanovic, J Schneider. A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful, the journal of Clinical Pharmacology, 1998, 38(7): 636-641.
  • 10Rosenstock J, Samols E, Muchmore DB, et al. Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Diabetes Care, 1996, 19(11): 1194-1199.

共引文献94

同被引文献10

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部